Back to School: How biopharma can reboot drug development. Access exclusive analysis here

User-friendly combinatorial chemistry

When Forward Ventures general partner Ivor Royston was first presented with new technology from The Scripps Research Institute for generating libraries of pharmacological compounds, the first question he asked was, why start another combinatorial chemistry company?

Royston came

Read the full 376 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers